Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ida Perrotta

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Cell Cycle (Georgetown, Tex.)|July 20, 2012
Estrogen receptor beta (ERβ) produces autophagy and necroptosis in human seminoma cell line through the binding of the Sp1 on the phosphatase and tensin homolog deleted from chromosome 10 (PTEN) promoter geneCarmela Guido, Salvatore Panza, Marta Santoro, et al.
Cell Proliferation|September 3, 2024
BET inhibitors (BETi) influence oxidative phosphorylation metabolism by affecting mitochondrial dynamics leading to alterations in apoptotic pathways in triple-negative breast cancer (TNBC) cellsTeresa Rossi, Egidio Iorio, Mattea Chirico, et al.
Nanoscale|September 16, 2021
Design and development of plastic antibodies against SARS-CoV-2 RBD based on molecularly imprinted polymers that inhibit <i>in vitro</i> virus infectionOrtensia Ilaria Parisi, Marco Dattilo, Francesco Patitucci, et al.
Journal of Translational Medicine|April 20, 2024
The redox-active defensive Selenoprotein T as a novel stress sensor protein playing a key role in the pathophysiology of heart failureAnna De Bartolo, Teresa Pasqua, Naomi Romeo, et al.
Cancers|September 24, 2020
Bortezomib-Loaded Mesoporous Silica Nanoparticles Selectively Alter Metabolism and Induce Death in Multiple Myeloma CellsAlessandra Nigro, Luca Frattaruolo, Mariarosa Fava, et al.
Molecular Cancer Therapeutics|May 20, 2016
Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple MyelomaNicola Amodio, Maria Angelica Stamato, Anna Maria Gullà, et al.
Haematologica|May 22, 2025
Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myelomaMaria Eugenia Gallo Cantafio, Ilenia Valentino, Roberta Torcasio, et al.
The Journal of Investigative Dermatology|June 21, 2019
Extracellular Vesicles in Human Skin: Cross-Talk from Senescent Fibroblasts to Keratinocytes by miRNAsLucia Terlecki-Zaniewicz, Vera Pils, Madhusudhan Reddy Bobbili, et al.
Cells|April 13, 2023
Palmitate-Induced Cardiac Lipotoxicity Is Relieved by the Redox-Active Motif of SELENOT through Improving Mitochondrial Function and Regulating Metabolic StateCarmine Rocca, Anna De Bartolo, Rita Guzzi, et al.
Antioxidants (Basel, Switzerland)|February 25, 2023
CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD<sup>+</sup>-Lowering AgentsPamela Becherini, Debora Soncini, Silvia Ravera, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Cell Cycle (Georgetown, Tex.)|July 20, 2012
Estrogen receptor beta (ERβ) produces autophagy and necroptosis in human seminoma cell line through the binding of the Sp1 on the phosphatase and tensin homolog deleted from chromosome 10 (PTEN) promoter geneCarmela Guido, Salvatore Panza, Marta Santoro, et al.
Cell Proliferation|September 3, 2024
BET inhibitors (BETi) influence oxidative phosphorylation metabolism by affecting mitochondrial dynamics leading to alterations in apoptotic pathways in triple-negative breast cancer (TNBC) cellsTeresa Rossi, Egidio Iorio, Mattea Chirico, et al.
Nanoscale|September 16, 2021
Design and development of plastic antibodies against SARS-CoV-2 RBD based on molecularly imprinted polymers that inhibit <i>in vitro</i> virus infectionOrtensia Ilaria Parisi, Marco Dattilo, Francesco Patitucci, et al.
Journal of Translational Medicine|April 20, 2024
The redox-active defensive Selenoprotein T as a novel stress sensor protein playing a key role in the pathophysiology of heart failureAnna De Bartolo, Teresa Pasqua, Naomi Romeo, et al.
Cancers|September 24, 2020
Bortezomib-Loaded Mesoporous Silica Nanoparticles Selectively Alter Metabolism and Induce Death in Multiple Myeloma CellsAlessandra Nigro, Luca Frattaruolo, Mariarosa Fava, et al.
Molecular Cancer Therapeutics|May 20, 2016
Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple MyelomaNicola Amodio, Maria Angelica Stamato, Anna Maria Gullà, et al.
Haematologica|May 22, 2025
Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myelomaMaria Eugenia Gallo Cantafio, Ilenia Valentino, Roberta Torcasio, et al.
The Journal of Investigative Dermatology|June 21, 2019
Extracellular Vesicles in Human Skin: Cross-Talk from Senescent Fibroblasts to Keratinocytes by miRNAsLucia Terlecki-Zaniewicz, Vera Pils, Madhusudhan Reddy Bobbili, et al.
Cells|April 13, 2023
Palmitate-Induced Cardiac Lipotoxicity Is Relieved by the Redox-Active Motif of SELENOT through Improving Mitochondrial Function and Regulating Metabolic StateCarmine Rocca, Anna De Bartolo, Rita Guzzi, et al.
Antioxidants (Basel, Switzerland)|February 25, 2023
CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD<sup>+</sup>-Lowering AgentsPamela Becherini, Debora Soncini, Silvia Ravera, et al.
Pageof 8